Healthcare provider profile · identity verified

Jeffrey B Mcginnis, M.D.

Allopathic & Osteopathic Physicians|Internal Medicine|Adolescent Medicine · MT STERLING, KY · NPI 1497704621

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Jeffrey B Mcginnis, M.D. received $98.95 in general payments during 2025 across 5 reported records.

Axsome Therapeutics, Inc. accounted for 46.7% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 6 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Auvelity, Ozempic, Rybelsus.

Axsome Therapeutics, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Auvelity as an associated drug or biological on 116023 records involving 35298 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Auvelity by this doctor in 2024.

Janssen Pharmaceuticals, Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported XARELTO as an associated drug or biological on 28 records involving 28 distinct recipient NPIs. Public Medicare Part D data also shows 77 claims for Xarelto by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 273 claims for Ozempic by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Rybelsus by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$98.95

5 reported records · 4 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Axsome Therapeutics, Inc.	Unresolved — no canonical attribution shown	$46.18	46.7%	2	2025
Janssen Pharmaceuticals, Inc	Unresolved — no canonical attribution shown	$20.25	20.5%	1	2025
Vanda Pharmaceuticals Inc.	Unresolved — no canonical attribution shown	$18.22	18.4%	1	2025
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$14.30	14.4%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$98.95	5

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Auvelity Normalized: auvelity	Drug	Axsome Therapeutics, Inc.	$46.18	2	2025
Source payment records 2025-02-20 · Axsome Therapeutics, Inc. · $19.40 · Open Payments source 2025-04-10 · Axsome Therapeutics, Inc. · $26.78 · Open Payments source
SPRAVATO Normalized: spravato	Drug	Janssen Pharmaceuticals, Inc	$20.25	1	2025
Source payment records 2025-04-17 · Janssen Pharmaceuticals, Inc · $20.25 · Open Payments source
FANAPT Normalized: fanapt	Drug	Vanda Pharmaceuticals Inc.	$18.22	1	2025
Source payment records 2025-05-27 · Vanda Pharmaceuticals Inc. · $18.22 · Open Payments source
HETLIOZ Normalized: hetlioz	Drug	Vanda Pharmaceuticals Inc.	$18.22	1	2025
Source payment records 2025-05-27 · Vanda Pharmaceuticals Inc. · $18.22 · Open Payments source
Ozempic Normalized: ozempic	Drug	Novo Nordisk Inc	$14.30	1	2025
Source payment records 2025-02-28 · Novo Nordisk Inc · $14.30 · Open Payments source
Rybelsus Normalized: rybelsus	Drug	Novo Nordisk Inc	$14.30	1	2025
Source payment records 2025-02-28 · Novo Nordisk Inc · $14.30 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
Auvelity auvelity	2025	Auvelity	2024	11 Beneficiary count suppressed	exact normalized	Medicare Part D
Ozempic ozempic	2025	Ozempic	2024	273	exact normalized	Medicare Part D
Rybelsus rybelsus	2025	Rybelsus	2024	14 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Axsome Therapeutics, Inc. Exact reporting entity; no affiliate inference	2025	Auvelity open payments reported associated product	CMS Open Payments — General Payments 116023 supporting records · 35298 recipient NPIs · example record 1235293064	Auvelity · 2024 Exact normalized brand match · 1 Part D row	11	suppressed by CMS
Janssen Pharmaceuticals, Inc Exact reporting entity; no affiliate inference	2025	XARELTO open payments reported associated product	CMS Open Payments — General Payments 28 supporting records · 28 recipient NPIs · example record 1174296970	Xarelto · 2024 Exact normalized brand match · 1 Part D row	77	18
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	273	34
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Rybelsus open payments reported associated product	CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076	Rybelsus · 2024 Exact normalized brand match · 1 Part D row	14	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	589	85
Atorvastatin Calcium	Atorvastatin Calcium	442	122
Levothyroxine Sodium	Levothyroxine Sodium	414	106
Pantoprazole Sodium	Pantoprazole Sodium	396	97
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	373	61
Alprazolam	Alprazolam	355	41
Omeprazole	Omeprazole	353	90
Rosuvastatin Calcium	Rosuvastatin Calcium	304	85
Losartan Potassium	Losartan Potassium	298	79
Amlodipine Besylate	Amlodipine Besylate	287	88
Ozempic	Semaglutide	273	34
Albuterol Sulfate Hfa	Albuterol Sulfate	268	55
Clonazepam	Clonazepam	250	35
Metoprolol Succinate	Metoprolol Succinate	240	63
Tramadol Hcl	Tramadol Hcl	227	44
Famotidine	Famotidine	188	52
Metformin Hcl	Metformin Hcl	183	52
Potassium Chloride	Potassium Chloride	176	54
Carvedilol	Carvedilol	174	52
Fluticasone Propionate	Fluticasone Propionate	167	35
Montelukast Sodium	Montelukast Sodium	167	47
Allopurinol	Allopurinol	163	40
Clopidogrel	Clopidogrel Bisulfate	162	40
Oxycodone Hcl	Oxycodone Hcl	160	23
Lisinopril	Lisinopril	154	45
Zolpidem Tartrate	Zolpidem Tartrate	153	21
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	151	40
Tamsulosin Hcl	Tamsulosin Hcl	146	42
Eliquis	Apixaban	144	29
Prednisone	Prednisone	141	79
Duloxetine Hcl	Duloxetine Hcl	139	29
Meloxicam	Meloxicam	131	47
Diazepam	Diazepam	129	17
Tizanidine Hcl	Tizanidine Hcl	127	31
Pregabalin	Pregabalin	125	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	124	17
Simvastatin	Simvastatin	124	33
Hydrochlorothiazide	Hydrochlorothiazide	119	39
Mounjaro	Tirzepatide	117	19
Doxazosin Mesylate	Doxazosin Mesylate	112	29
Lorazepam	Lorazepam	108	21
Repaglinide	Repaglinide	108	29
Cefuroxime	Cefuroxime Axetil	106	82
Furosemide	Furosemide	101	30
Hydroxyzine Hcl	Hydroxyzine Hcl	100	22
Citalopram Hbr	Citalopram Hydrobromide	99	27
Januvia	Sitagliptin Phosphate	94	17
Amitriptyline Hcl	Amitriptyline Hcl	92	15
Ondansetron Odt	Ondansetron	92	26
Jardiance	Empagliflozin	86	21
Sertraline Hcl	Sertraline Hcl	86	20
Trulicity	Dulaglutide	86	15
Temazepam	Temazepam	85	suppressed
Trazodone Hcl	Trazodone Hcl	85	21
Olmesartan Medoxomil	Olmesartan Medoxomil	83	27
Bumetanide	Bumetanide	79	21
Diclofenac Sodium	Diclofenac Sodium	77	28
Metoprolol Tartrate	Metoprolol Tartrate	77	20
Xarelto	Rivaroxaban	77	18
Benazepril Hcl	Benazepril Hcl	75	20
Bupropion Xl	Bupropion Hcl	75	14
Glimepiride	Glimepiride	74	24
Metformin Hcl Er	Metformin Hcl	72	20
Ezetimibe	Ezetimibe	70	21
Buspirone Hcl	Buspirone Hcl	69	17
Bisoprolol Fumarate	Bisoprolol Fumarate	68	17
Atenolol	Atenolol	67	18
Farxiga	Dapagliflozin Propanediol	66	12
Escitalopram Oxalate	Escitalopram Oxalate	64	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	64	16
Celecoxib	Celecoxib	63	18
Linzess	Linaclotide	60	17
Baclofen	Baclofen	59	suppressed
Nebivolol Hcl	Nebivolol Hcl	59	13
Ropinirole Hcl	Ropinirole Hcl	59	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	58	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	55	15
Paroxetine Hcl	Paroxetine Hcl	55	11
Fluoxetine Hcl	Fluoxetine Hcl	54	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	16
Ibuprofen	Ibuprofen	53	14
Cephalexin	Cephalexin	52	41
Mupirocin	Mupirocin	52	27
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	52	12
Venlafaxine Hcl Er	Venlafaxine Hcl	52	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	12
Spironolactone	Spironolactone	51	17
Meclizine Hcl	Meclizine Hcl	50	14
Pravastatin Sodium	Pravastatin Sodium	50	11
Fluconazole	Fluconazole	48	30
Synthroid	Levothyroxine Sodium	48	suppressed
Colestipol Hcl	Colestipol Hcl	47	14
Tradjenta	Linagliptin	47	11
Finasteride	Finasteride	46	14
Quetiapine Fumarate	Quetiapine Fumarate	46	suppressed
Donepezil Hcl	Donepezil Hcl	45	12
Doxycycline Hyclate	Doxycycline Hyclate	45	25
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	44	suppressed
Alendronate Sodium	Alendronate Sodium	41	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	11
Memantine Hcl Er	Memantine Hcl	40	suppressed
Fenofibrate	Fenofibrate	39	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	38	suppressed
Torsemide	Torsemide	38	11
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	37	13
Dicyclomine Hcl	Dicyclomine Hcl	37	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	14
Metoclopramide Hcl	Metoclopramide Hcl	36	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	36	suppressed
Estradiol	Estradiol	35	11
Methocarbamol	Methocarbamol	34	14
Topiramate	Topiramate	34	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	33	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Tresiba Flextouch U-100	Insulin Degludec	32	suppressed
Raloxifene Hcl	Raloxifene Hcl	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	22
Ventolin Hfa	Albuterol Sulfate	31	suppressed
Azithromycin	Azithromycin	30	23
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	21
Lidocaine	Lidocaine	29	suppressed
Verapamil Er	Verapamil Hcl	29	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	28	suppressed
Levofloxacin	Levofloxacin	28	23
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Ubrelvy	Ubrogepant	27	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	26	suppressed
Dexlansoprazole Dr	Dexlansoprazole	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	26	suppressed
Ramipril	Ramipril	26	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	25	suppressed
Cefdinir	Cefdinir	25	22
Glipizide	Glipizide	25	suppressed
Lansoprazole	Lansoprazole	25	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Valsartan	Valsartan	24	11
Warfarin Sodium	Warfarin Sodium	24	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Dexilant	Dexlansoprazole	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Loperamide	Loperamide Hcl	22	suppressed
Methotrexate	Methotrexate Sodium	22	suppressed
Xifaxan	Rifaximin	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	19
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	suppressed
Nitroglycerin	Nitroglycerin	21	16
Valacyclovir	Valacyclovir Hcl	21	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	15
Sucralfate	Sucralfate	19	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Amoxicillin	Amoxicillin	18	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Cilostazol	Cilostazol	18	suppressed
Clotrimazole	Clotrimazole	18	suppressed
Colesevelam Hcl	Colesevelam Hcl	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Premarin	Estrogens, Conjugated	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Felodipine Er	Felodipine	17	suppressed
Fenofibrate	Fenofibrate,micronized	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Nystatin	Nystatin	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Colchicine	Colchicine	16	suppressed
Dapagliflozin	Dapagliflozin Propanediol	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	16	suppressed
Zaleplon	Zaleplon	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Lactulose	Lactulose	15	suppressed
Movantik	Naloxegol Oxalate	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Prempro	Estrogen,con/M-Progest Acet	15	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	14	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Belsomra	Suvorexant	13	suppressed
Dilt-Xr	Diltiazem Hcl	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Glyburide	Glyburide	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Jentadueto	Linagliptin/Metformin Hcl	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Theophylline Er	Theophylline Anhydrous	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Naproxen	Naproxen	12	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	12	suppressed
Auvelity	Dextromethorphan Hbr/Bupropion	11	suppressed
Cosentyx (2 Syringes)	Secukinumab	11	suppressed
Desloratadine	Desloratadine	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Savella	Milnacipran Hcl	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$98.95 · 5 records	Axsome Therapeutics, Inc.	Auvelity, FANAPT, HETLIOZ, Ozempic, Rybelsus, SPRAVATO	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Auvelity play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Axsome Therapeutics, Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error